ProLung Inc - Ordinary Shares

The momentum for this stock is not very good. ProLung Inc - Ordinary Shares is not a good value stock. ProLung Inc - Ordinary Shares is not very popular among insiders. ProLung Inc - Ordinary Shares is a mediocre stock to choose.
Log in to see more information.
ProLung, Inc. is a medical technology company, which specializes in predictive analytics technology...
LUNG Fundamental Data by TradingView

News

Pulmonx presents clinical data from COVERT, LIBERATE trials at ERS
Pulmonx presents clinical data from COVERT, LIBERATE trials at ERS

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Pulmonx Announces Presentation of Clinical Data from the AeriSeal CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
Pulmonx Announces Presentation of Clinical Data from the AeriSeal CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024

Globe Newswire CONVERT trial data demonstrate AeriSeal System is safe and effective with 77.6% of patients converted from CV+ to CV- 5-year durability data from LIBERATE study demonstrate positive, durable...\n more…

Pulmonx Co. (NASDAQ:LUNG) Receives Average Recommendation of "Moderate Buy" from Brokerages
Pulmonx Co. (NASDAQ:LUNG) Receives Average Recommendation of "Moderate Buy" from Brokerages

Ticker Report Shares of Pulmonx Co. (NASDAQ:LUNG - Get Free Report) have received an average rating of "Moderate Buy" from the six research firms that are currently covering the firm, Marketbeat Ratings reports...\n more…

Wells Fargo Reaffirms Their Hold Rating on Pulmonx (LUNG)
Wells Fargo Reaffirms Their Hold Rating on Pulmonx (LUNG)

TipRanks Financial Blog In a report released on September 6, Larry Biegelsen from Wells Fargo maintained a Hold rating on Pulmonx (LUNG - Research Report). The company's s...\n more…

Insider Selling: Pulmonx Co. (NASDAQ:LUNG) Insider Sells $30,726.20 in Stock
Insider Selling: Pulmonx Co. (NASDAQ:LUNG) Insider Sells $30,726.20 in Stock

Ticker Report Pulmonx Co. (NASDAQ:LUNG - Get Free Report) insider Geoffrey Beran Rose sold 4,586 shares of the company's stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an...\n more…

Insider Selling: Pulmonx Co. (NASDAQ:LUNG) General Counsel Sells 5,765 Shares of Stock
Insider Selling: Pulmonx Co. (NASDAQ:LUNG) General Counsel Sells 5,765 Shares of Stock

Ticker Report Pulmonx Co. (NASDAQ:LUNG - Get Free Report) General Counsel David Aaron Lehman sold 5,765 shares of Pulmonx stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price...\n more…